Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
Abstract Soft tissue sarcomas (STS) are rare and heterogeneous tumours comprising over 80 different histological subtypes. Treatment options remain limited in advanced STS with high rates of recurrence following resection of localised disease. Prognostication in clinical practice relies predominantl...
Guardado en:
Autores principales: | Eve Merry, Khin Thway, Robin L. Jones, Paul H. Huang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/124e621bfb764b3aaed8a52393b55b67 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Molecular targeted therapy for advanced or metastatic soft tissue sarcoma
por: Jin Yuan MD, et al.
Publicado: (2021) -
A Novel Four-Gene Prognostic Signature for Prediction of Survival in Patients with Soft Tissue Sarcoma
por: Changwu Wu, et al.
Publicado: (2021) -
A Successful Chemoembolization of a Retroperitoneal Soft Tissue Sarcoma: A Case Report
por: Waldec Jorge David Filho, et al.
Publicado: (2021) -
A DNA damage repair gene‐associated signature predicts responses of patients with advanced soft‐tissue sarcoma to treatment with trabectedin
por: David S. Moura, et al.
Publicado: (2021) -
WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
por: Esther Martinez-Font, et al.
Publicado: (2021)